Avoiding Chemo In Breast Cancer; Psychedelic Medication For Depression

A Texas Tech podcast reviewed research on PET-guided chemotherapy reduction in HER2-positive breast cancer and intranasal mebufotenin for depression.

Oral LSD Drug Hits Phase III Endpoints In Anxiety, Depression

Definium says its single-dose oral LSD formulation met primary endpoints in two Phase III trials; the results have not yet established approval or long-term safety.

Dismantling Ageism From Within After 60

A Sixty and Me essay urges people over 60 to challenge internalized age-related beliefs through self-care, creative expression and other practices.

Obesity Drugs May Help Protect Memory And Cognitive Abilities

A Science review examines whether GLP-1 obesity drugs could protect cognition, while human evidence remains mixed and Alzheimer’s trials were negative.

Here’s How The Blue Tsunami Will Turn The Healthcare Tide

A MedPage Today analysis says Democrats may pursue health priorities in 2027, but funding, vetoes and Senate procedure could limit what they achieve.

What The Happiest Retirees Have In Common (It’s Not Money)

A Sixty and Me report highlights relationships, purpose, activity and adaptation as habits associated with a more satisfying retirement.

The Changing Landscape Of Our Lives

Senior life coach Marvin Weinbaum reflects on how retirement changes daily priorities and invites people to shape the next stage of life.

My Experience In New York City

A Sixty and Me writer describes navigating New York City at 75 after receiving concerning eye news, and finding comfort in a friend’s shared caution.

New NHS-ready Medication Risk Tool Could Cut Falls And Delirium In Older People

A medication risk index developed with data from nearly 750,000 older adults is live in two NHS trusts and being piloted in hospital wards.

Tau Spreads More Rapidly In Early-onset Alzheimer’s Disease

A study found tau accumulated at more than twice the rate in early-onset Alzheimer’s, with broader spread than in later-onset disease.